Rankings
▼
Calendar
ARVN Q4 2021 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$26M
+1085.9% YoY
Gross Profit
$25M
94.1% margin
Operating Income
-$54M
-206.8% margin
Net Income
-$53M
-201.5% margin
EPS (Diluted)
$-1.00
QoQ Revenue Growth
+182.8%
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$38M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$800M
Stockholders' Equity
$782M
Cash & Equivalents
$108M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$26M
$2M
+1085.9%
Gross Profit
$25M
$2M
+1015.7%
Operating Income
-$54M
-$43M
-25.9%
Net Income
-$53M
-$42M
-27.6%
← FY 2021
All Quarters
Q1 2022 →